HS/KN-kode 30021010 er ikke omfattet til EUDR-forberedelse.
Antisera(2012-2016);Antisera(2002-2011);Antisera(1988-2001) Den indekserede anvendelsesområde-motor returnerer Out of scope for denne kode. No Annex I scope match was found for this indexed CN code.
Hvorfor denne referenceside giver dette svar.
- Kodebeskrivelse
- Antisera(2012-2016);Antisera(2002-2011);Antisera(1988-2001)
- Bilag I-grundlag
- Ingen direkte bilag I-post
- Kildegrundlag
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Overordnet, underordnet og nærliggende rækker.
Biblioteksvisningen er til referencenavigation. Brug tjekkeren, når du vil køre en anden kode som en handling.
30farmaceutiske produkterout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021091haemoglobin, blood globulins and serum globulins(2012-2016);haemoglobin, blood globulins and serum globulins(2002-2011);haemoglobin, blood globulins and serum globulins(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021098blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Hvad dette betyder for forberedelsen.
Denne række udløser ikke direkte indsamling af dokumentation i det aktuelle anvendelsesområde-resultat.
Regulation (EU) 2023/1115 Annex I — relevant productshentet 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115hentet 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)hentet 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)hentet 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8hentet 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkinghentet 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradershentet 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)hentet 2026-08-08